H

Hoth Therapeutics

HOTH

0.68530
USD
-0.0019
(-0.28%)
مغلق
حجم التداول
1,447
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
5,937,271
أصول ذات صلة
A
ADMP
0
(0%)
0.000000 USD
A
ATOS
-0.05000
(-3.70%)
1.30000 USD
G
GERN
0.03500
(0.74%)
4.78500 USD
O
ONTX
0
(0%)
0.000000 USD
P
PTN
-0.03000
(-1.79%)
1.65000 USD
S
SLS
0.08000
(6.90%)
1.24000 USD
S
SYBX
-0.01000
(-0.59%)
1.68000 USD
T
TTOO
0.16000
(3.31%)
4.99000 USD
V
VTVT
0.010
(0.07%)
14.540 USD
الأخبار المقالات

العنوان: Hoth Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.